-
Product Name
Sapelizumab (Synonyms: SATRALIZUMAB [USAN]; SATRALIZUMAB [MI])
- Documents
-
Description
Anti-IL-6Ra / CD126 Antibody (Sapelizumab)
-
Tested applications
ELISA
-
Species reactivity
Human IL-6Ra / CD126
-
Alternative names
SATRALIZUMAB [USAN] antibody; SATRALIZUMAB [MI] antibody; SATRALIZUMAB [JAN] antibody; satralizumab [INN] antibody; Satralizumab [WHO-DD] antibody
-
Isotype
IgG2SA
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
0.1 M Pro-Ac, 20 mM Arg, pH 5.0
-
Storage instructions
-80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
-
Validations
SDS-PAGE
Anti-IL-6Ra / CD126 Antibody (sapelizumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 90%.
SEC-HPLC
The purity of Anti-IL-6Ra / CD126 Antibody (sapelizumab) is more than 95%, determined by SEC-HPLC.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"